FDA Approved: KEPPRA — Supplemental Application (UCB, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Keppra (levetiracetam) from UCB, Inc., expanding the product's approved use and/or labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Keppra (levetiracetam)

Snippet

SUPPL AP for KEPPRA (LEVETIRACETAM)